| 1 |
33273014 | mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | 2021 Jan-Jun |
2 |
| 2 |
28916818 | Identification of 4-phenylquinolin-2(1H)-one as a specific allosteric inhibitor of Akt. | 2017 Sep 15 |
1 |
| 3 |
27026523 | mTORC1 is necessary but mTORC2 and GSK3β are inhibitory for AKT3-induced axon regeneration in the central nervous system. | 2016 Mar 30 |
1 |
| 4 |
27197158 | Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers. | 2016 Aug 15 |
1 |
| 5 |
24615340 | Identification of mTORC2 as a necessary component of HRG/ErbB2-dependent cellular transformation. | 2014 Jun |
1 |
| 6 |
23596569 | Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer Cells. | 2013 |
1 |
| 7 |
21464307 | IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation. | 2011 Apr 19 |
1 |
| 8 |
22140653 | mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling. | 2011 Aug |
1 |